DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
September 15 2020 - 8:15AM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage
biotechnology company, has been invited to present at Lake Street’s
4th Annual Best Ideas Growth (BIG4) Conference, being held on
Thursday, September 17, 2020, on a virtual platform.
DiaMedica Therapeutics management is scheduled to meet with
investors Thursday, September 17th, with one-on-one and group
meetings to be held throughout the day. To receive additional
information, request an invitation or to schedule a one-on-one
meeting, please email conference@lakestreetcm.com.
About the BIG4 Conference
Lake Street will host its 4th annual Best Ideas Growth (BIG4)
Conference on a virtual platform, showcasing many interesting and
dynamic public growth companies. Executives from approximately 90
publicly traded companies will meet institutional investors in an
interactive, one-on-one format. This is an invitation-only event
attended by top institutional investors from across the
country.
For more information, visit
https://www.lakestreetcapitalmarkets.com/big4conference, contact
your Lake Street representative, email conference@lakestreetcm.com,
or call 612-326-1305.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for neurological and kidney diseases. DiaMedica’s common shares are
listed on The Nasdaq Capital Market under the trading symbol
“DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200915005161/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024